Loqoa Tape (esflurbiprofen transdermal)
/ Taisho
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 08, 2026
Comparison of transdermal and oral anti-inflammatory drugs on immediate post-operative pain control in total knee arthroplasty: a randomized controlled trial.
(PubMed, Arthroplasty)
- "A multimodal pain control regimen in TKA using a transdermal Esflurbiprofen patch provided immediate post-operative pain control that was non-inferior to oral Celecoxib, with comparable VAS, functional outcomes, and safety profiles."
Journal • Anesthesia • Immunology • Orthopedics • Osteoarthritis • Pain • Rheumatology
August 20, 2021
Safety and Efficacy of SFPP in Knee Osteoarthritis
(clinicaltrials.gov)
- P3; N=313; Completed; Sponsor: Taisho Pharmaceutical Co., Ltd.; Recruiting ➔ Completed; Trial completion date: May 2021 ➔ Jan 2021
Clinical • Trial completion • Trial completion date • Immunology • Musculoskeletal Pain • Osteoarthritis • Pain • Rheumatology
November 21, 2018
LncRNAs expression in adriamycin-induced rats reveals the potential role of LncRNAs contributing to chronic glomerulonephritis pathogenesis.
(PubMed, Gene)
- "The ten LncRNAs were differentially expressed and might play important roles in the development of CGN. Key genes, such as Il6, Ptprc, TOP2a, Fos, Myc, etc., may be crucial biomarkers for CGN."
Biomarker • Journal
1 to 3
Of
3
Go to page
1